Healthcare Sales & Marketing Network News: chemoproteomic

Searching News Database: chemoproteomic

HSMN NewsFeed - 22 Mar 2023
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Jul 2022
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 May 2021
BridGene Biosciences Announces $12 Million Series A Financing to Advance the Company's Proprietary Chemoproteomic Platform and Pipeline of Oncology Programs
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 2 Dec 2020
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2018
Abide and Celgene Enter Worldwide License Agreement for ABX-1772
Biopharmaceuticals Licensing

Return to NewsFeed

Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 2 additional stories matching:
chemoproteomic
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.